🇺🇸 Stem Cell Transplantation in United States

22 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 22

Most-reported reactions

1. Idiopathic Pneumonia Syndrome — 3 reports (13.64%)
2. Multi-Organ Failure — 3 reports (13.64%)
3. Stem Cell Transplant — 3 reports (13.64%)
4. Diarrhoea — 2 reports (9.09%)
5. Drug Toxicity — 2 reports (9.09%)
6. Mucosal Inflammation — 2 reports (9.09%)
7. Neutropenia — 2 reports (9.09%)
8. Pyrexia — 2 reports (9.09%)
9. Thrombocytopenia — 2 reports (9.09%)
10. Anaemia — 1 report (4.55%)

Source database →

Frequently asked questions

Is Stem Cell Transplantation approved in United States?

Stem Cell Transplantation does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Stem Cell Transplantation in United States?

Stem Cells Arabia is the originator. The local marketing authorisation holder may differ — check the official source linked above.